1. From the University de Paris, INSERM, U970, Paris Cardiovascular Research Centre (PARCC), Integrative Epidemiology of Cardiovascular Disease Team, France (R.E.C., M.-C.P., L.O., C.G., T.T.v.S., X.J., J.-P.E.)
2. Baker Heart and Diabetes Institute, Melbourne, Australia (R.E.C.)
3. Menzies Institute for Medical Research, University of Tasmanian, Hobart, Australia (R.E.C., J.E.S.)
4. INSERM U970, Department of Pharmacology, APHP, Paris Descartes University, France (P.B., S.L.)
5. APHP, University de Paris, France (E.C., M.P.)
6. Cardiovascular Research Institute Maastricht and Department of Internal Medicine, Maastricht University Medical Centre, the Netherlands (T.T.v.S.)
7. Investigations Préventives et cliniques (IPC), Paris, France (F.T., B.P.).